Follow us for updates
© 2021 reportr.world
Read the Story →

Human Rights Lawyer Neri Colmenares Will Run For Senate in 2022

To challenge Duterte's candidates.
by Pia Regalado
8 hours ago
Photo/s: Neri Colmenares/Facebook
Shares

Human rights lawyer and former party-list congressman Neri Colmenares said Thursday he would run for senator in 2022 to challenge President Rodrigo Duterte's candidates.

The former Bayan Muna representative said Duterte should expect from him the "sharpest" critique directed at administration bets. Colmenares lost in his 2019 campaign for a seat in the Senate.

"The officers, leaders of Makabayan have decided that I will run. I will file my certificate of candidacy," he said in an ANC interview.

Colmenares, who is a part of 1Sambayan, continues to rally for a united opposition to defeat President Duterte in the 2022 polls.

READ: Seeing Do or Die, Opposition Moves to Unite for 2022 Elections

Efforts to form the broadest opposition coalition is not over, even when some of 1Sambayan's potential presidential candidates had announced their bid for the presidency, he said.

ALSO READ: Isko Moreno, Eyeing Presidency, Wants Millennials in Government

"The fact that the opposition can stil unify after the filing of the certificates of candidacy for example, there could be talks among the opposition members during that period," he said.

Continue reading below ↓

"There is still hope."

Continue reading below ↓
Recommended Videos

Reportr is now on Quento. Download the app or visit the Quento website for more articles and videos from Reportr and your favorite websites.

Latest Headlines
Read Next
Recent News
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.